Literature DB >> 3875873

DSM-III generalized anxiety disorder: an empirical investigation of more stringent criteria.

N Breslau, G C Davis.   

Abstract

The diagnoses of generalized anxiety disorder (GAD) according to DSM-III and according to revised criteria (requiring 6 months' duration and 6 symptoms) were determined by the use of the National Institute of Mental Health Diagnostic Interview Schedule in a probability sample of 357 women. The DSM-III GAD lifetime rate of 45% was reduced by a factor of five when the revised definition was applied. The reduction was due chiefly to the longer duration criterion. Requiring a higher number of symptoms did not raise the threshold for the diagnosis, since 74% of persons with a period of 1 month or more of generalized anxiety reported six symptoms. Although chronicity was associated with more pervasive symptomatology, the excess in symptoms appears to be due to the very high prevalence of major depression (73%) among the newly defined (i.e., chronic) GAD positives.

Entities:  

Mesh:

Year:  1985        PMID: 3875873     DOI: 10.1016/0165-1781(85)90080-0

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

1.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

2.  Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication.

Authors:  Ayelet Meron Ruscio; Wai Tat Chiu; Peter Roy-Byrne; Paul E Stang; Dan J Stein; Hans-Ulrich Wittchen; Ronald C Kessler
Journal:  J Anxiety Disord       Date:  2006-11-21

3.  Generalized anxiety disorder and anorexia nervosa: evidence of shared genetic variation.

Authors:  Jocilyn E Dellava; Kenneth S Kendler; Michael C Neale
Journal:  Depress Anxiety       Date:  2011-05-26       Impact factor: 6.505

4.  Models of comorbidity for multifactorial disorders.

Authors:  M C Neale; K S Kendler
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

5.  Depressive comorbidity in children and adolescents with generalized anxiety disorder.

Authors:  G Masi; L Favilla; M Mucci; S Millepiedi
Journal:  Child Psychiatry Hum Dev       Date:  2000

6.  Mixed Anxiety and Depression : Diagnosis and Treatment Options.

Authors:  D Bakish; R Habib; C L Hooper
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 7.  Relationship of anxiety and depression.

Authors:  A Frances; D Manning; D Marin; J Kocsis; K McKinney; W Hall; M Kline
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries.

Authors:  S Lee; A Tsang; A M Ruscio; J M Haro; D J Stein; J Alonso; M C Angermeyer; E J Bromet; K Demyttenaere; G de Girolamo; R de Graaf; O Gureje; N Iwata; E G Karam; J-P Lepine; D Levinson; M E Medina-Mora; M A Oakley Browne; J Posada-Villa; R C Kessler
Journal:  Psychol Med       Date:  2008-12-18       Impact factor: 7.723

9.  CLASSIFICATION OF ANXIETY DISORDERS COMORBID WITH MAJOR DEPRESSION: COMMON OR DISTINCT INFLUENCES ON RISK?

Authors:  Arden Moscati; Jonathan Flint; Kenneth S Kendler
Journal:  Depress Anxiety       Date:  2015-09-29       Impact factor: 6.505

10.  Anxiety: its role in the history of psychiatric epidemiology.

Authors:  J M Murphy; A H Leighton
Journal:  Psychol Med       Date:  2008-10-22       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.